Results 141 to 150 of about 55,807 (330)

Euglycemic diabetic ketoacidosis: another masquerader! [PDF]

open access: yes, 2019
Euglycemic ketoacidosis is defined by the triad of euglycemia, metabolic acidosis and ketonemia or ketonuria. In the current era of diabetic management, it is a serious concern with the usage of sodium glucose co-transporter 2 (SGLT2) inhibitors ...
Kumar, Bhargavi   +2 more
core   +2 more sources

Guidelines for the management of diabetes‐related ketoacidosis (DKA) have been poorly adopted and implemented, resulting in a lack of improvement in outcomes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims The Joint British Diabetes Society‐Inpatient (JBDS‐IP) group recommends reducing fixed rate intravenous insulin infusion (FRIII) from 0.1 to 0.05 units/kg/h when blood glucose falls <14 mmol/L to reduce the risk of complications associated with acute management of diabetes‐related ketoacidosis. However, whether this change results in real‐
Angelica Sharma   +35 more
wiley   +1 more source

Pseudomyocardial Infarction in a Patient with Severe Diabetic Ketoacidosis and Mild Hyperkalemia

open access: yesCase Reports in Cardiology, 2019
A 48-year-old male with a prior diagnosis of diabetes mellitus presented to the emergency department with malaise and nausea.
Edgar Francisco Carrizales-Sepúlveda   +8 more
doaj   +1 more source

Managing discordance between HbA1c and glucose management indicator

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims The assessment of haemoglobin A1c (HbA1c) continues to play an essential role in diabetes care; however, major advances in new technologies widen the armament available to clinicians to further refine treatment for their patients. Whilst HbA1c remains a critical glycaemic marker, advances in technologies such as Continuous Glucose ...
Erna Lenters‐Westra   +6 more
wiley   +1 more source

“The Proof is in the Pudding”: Do SGLT2 Inhibitors Cause Diabetic Ketoacidosis?

open access: yesAACE Clinical Case Reports, 2018
Abbreviations: DKA diabetic ketoacidosis EuDKA euglycemic diabetic ketoacidosis SGLT2i sodium-glucose cotransporter 2 inhibitors T2DM type 2 diabetes ...
Elena Barengolts, MD
doaj  

PRECIPITATING FACTORS FOR DIABETIC KETOACIDOSIS

open access: yesKhyber Medical University Journal, 2009
Objective; To determine the frequency of various precipitating factors for Diabetic Ketoacidosis (DKA). Material and Methods: This descriptive, cross-sectional study based on purposive sampling method was conducted at Medical ward VI, Islamabad Hospital,
Danish Naveed   +3 more
doaj  

LIJEČENJE TEŠKE DIJABETIČKE KETOACIDOZE U MLADE OSOBE [PDF]

open access: yes, 2019
We present a case of severe diabetic ketoacidosis in a 19-year-old male with a history of poor compliance to insulin therapy. At arrival to our Emergency Department, the patient was comatose with extreme hyperglycemia, severe diabetic ketoacidosis ...
GORANA MIROŠEVIĆ   +4 more
core   +1 more source

Impact of Simplera Sync™ sensors and Extended™ Wear Infusion Sets on glycaemia and system performance of the MiniMed™ 780G system in children and young adults with previously high HbA1c

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims The MiniMed™ 780G improves glycaemia and reduces burden in type 1 diabetes. We investigated how new all‐in‐one “Simplera Sync™” sensors and 7‐day Extended™ Wear Infusion Sets (EIS) affect glycaemia and system performance in young people with previously elevated HbA1c levels (≥69 mmol/mol [≥8%]) after transitioning from 780G with Guardian ...
Venus R. Michaels   +8 more
wiley   +1 more source

Significance of Hyperamylasaemia and Abdominal Pain in Diabetic Ketoacidosis [PDF]

open access: bronze, 1973
A H Knight   +3 more
openalex   +1 more source

An overview of insulin therapy for the non‐specialist

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Nearly all health professionals, whatever their practice or speciality, now have contact with a significant number of insulin‐using people with diabetes. People with type 1 diabetes are nearly universally managed on more complex insulin regimens, increasingly with complex support technology, and with some understanding of the concepts ...
Philip D. Home
wiley   +1 more source

Home - About - Disclaimer - Privacy